PDB Short entry for 2XFQ HEADER OXIDOREDUCTASE 26-MAY-10 2XFQ TITLE RASAGILINE-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2- TITLE 2 BENZOFURANYL)-2-IMIDAZOLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMINE OXIDASE [FLAVIN-CONTAINING] B; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MONOAMINE OXIDASE TYPE B,MAO-B; COMPND 5 EC: 1.4.3.4; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAOB; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS FLAVOPROTEIN, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR D.BONIVENTO,E.M.MILCZEK,G.R.MCDONALD,C.BINDA,A.HOLT,D.E.EDMONDSON, AUTHOR 2 A.MATTEVI REVDAT 6 17-OCT-18 2XFQ 1 TITLE COMPND SOURCE REMARK REVDAT 6 2 1 DBREF REVDAT 5 16-MAY-18 2XFQ 1 REMARK REVDAT 4 20-DEC-17 2XFQ 1 JRNL REVDAT 3 29-FEB-12 2XFQ 1 REMARK VERSN HETNAM HETSYN REVDAT 3 2 1 FORMUL REVDAT 2 24-NOV-10 2XFQ 1 JRNL REVDAT 1 06-OCT-10 2XFQ 0 JRNL AUTH D.BONIVENTO,E.M.MILCZEK,G.R.MCDONALD,C.BINDA,A.HOLT, JRNL AUTH 2 D.E.EDMONDSON,A.MATTEVI JRNL TITL POTENTIATION OF LIGAND BINDING THROUGH COOPERATIVE EFFECTS JRNL TITL 2 IN MONOAMINE OXIDASE B. JRNL REF J. BIOL. CHEM. V. 285 36849 2010 JRNL REFN ESSN 1083-351X JRNL PMID 20855894 JRNL DOI 10.1074/JBC.M110.169482 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 62931 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 REFLECTION IN BIN (WORKING SET) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE SET COUNT : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7914 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 182 REMARK 3 SOLVENT ATOMS : 472 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : NULL REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2XFQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1290043801. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64575 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.20600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 1S2Q REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 65.75500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 111.69000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 65.75500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 111.69000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 65.75500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 111.69000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 65.75500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 111.69000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2003 LIES ON A SPECIAL POSITION. REMARK 375 HOH B2154 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 PHE A 502 REMARK 465 SER A 503 REMARK 465 ALA A 504 REMARK 465 THR A 505 REMARK 465 ALA A 506 REMARK 465 LEU A 507 REMARK 465 GLY A 508 REMARK 465 PHE A 509 REMARK 465 LEU A 510 REMARK 465 ALA A 511 REMARK 465 HIS A 512 REMARK 465 LYS A 513 REMARK 465 ARG A 514 REMARK 465 GLY A 515 REMARK 465 LEU A 516 REMARK 465 LEU A 517 REMARK 465 VAL A 518 REMARK 465 ARG A 519 REMARK 465 VAL A 520 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 497 REMARK 465 LEU B 498 REMARK 465 THR B 499 REMARK 465 THR B 500 REMARK 465 ILE B 501 REMARK 465 PHE B 502 REMARK 465 SER B 503 REMARK 465 ALA B 504 REMARK 465 THR B 505 REMARK 465 ALA B 506 REMARK 465 LEU B 507 REMARK 465 GLY B 508 REMARK 465 PHE B 509 REMARK 465 LEU B 510 REMARK 465 ALA B 511 REMARK 465 HIS B 512 REMARK 465 LYS B 513 REMARK 465 ARG B 514 REMARK 465 GLY B 515 REMARK 465 LEU B 516 REMARK 465 LEU B 517 REMARK 465 VAL B 518 REMARK 465 ARG B 519 REMARK 465 VAL B 520 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 150 CD GLU B 150 OE2 0.068 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 47 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG A 47 NE - CZ - NH2 ANGL. DEV. = -4.4 DEGREES REMARK 500 ARG A 445 NE - CZ - NH1 ANGL. DEV. = 5.1 DEGREES REMARK 500 ARG A 445 NE - CZ - NH2 ANGL. DEV. = -6.4 DEGREES REMARK 500 ARG A 448 NE - CZ - NH1 ANGL. DEV. = 7.0 DEGREES REMARK 500 ARG A 448 NE - CZ - NH2 ANGL. DEV. = -7.4 DEGREES REMARK 500 ARG B 47 NE - CZ - NH1 ANGL. DEV. = 4.9 DEGREES REMARK 500 ARG B 47 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 ARG B 445 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG B 445 NE - CZ - NH2 ANGL. DEV. = -5.2 DEGREES REMARK 500 ARG B 448 NE - CZ - NH1 ANGL. DEV. = 6.6 DEGREES REMARK 500 ARG B 448 NE - CZ - NH2 ANGL. DEV. = -8.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 52 -69.69 66.70 REMARK 500 SER A 59 -51.28 -152.52 REMARK 500 THR A 64 -5.10 80.50 REMARK 500 ALA A 133 68.50 -161.48 REMARK 500 THR A 201 -81.20 -91.17 REMARK 500 ALA A 346 -124.99 55.23 REMARK 500 GLU A 379 56.16 -116.14 REMARK 500 ASP A 419 -101.62 63.13 REMARK 500 ALA A 424 -147.51 -109.20 REMARK 500 THR A 500 33.34 -68.45 REMARK 500 LYS B 52 -74.20 69.37 REMARK 500 SER B 59 -51.24 -146.14 REMARK 500 THR B 64 -4.27 81.31 REMARK 500 LYS B 93 54.91 38.43 REMARK 500 ALA B 133 70.50 -160.86 REMARK 500 THR B 201 -74.11 -89.21 REMARK 500 ALA B 346 -126.67 57.16 REMARK 500 ASP B 419 -102.13 60.78 REMARK 500 ALA B 424 -149.98 -109.14 REMARK 500 LEU B 495 43.74 -83.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 FLAVIN-ADENINE DINUCLEOTIDE (FAD): N5 ATOM OF FAD IS REMARK 600 COVALENTLY ATTACHED TO C13 ATOM OF RAS REMARK 600 N-PROPARGYL-1(R)-AMINOINDAN (RASAGILINE) (RAS): C13 ATOM OF REMARK 600 RAS IS COVALENTLY ATTACHED TO N5 ATOM OF FAD REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XCG A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C15 A 1503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XCG B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF RESIDUES 600 TO 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF RESIDUES 600 TO 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C67 RELATED DB: PDB REMARK 900 MAO INHIBITION BY RASAGILINE ANALOGUES REMARK 900 RELATED ID: 1OJA RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH ISATIN REMARK 900 RELATED ID: 2V5Z RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR REMARK 900 SAFINAMIDE REMARK 900 RELATED ID: 1S3E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH 6-HYDROXY-N-PROPARGYL-1(R) REMARK 900 -AMINOINDAN REMARK 900 RELATED ID: 2C73 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 1OJB RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH TRANYLCYPROMINE REMARK 900 RELATED ID: 2V60 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7- REMARK 900 (3-CHLOROBENZYLOXY )-4-CARBOXALDEHYDE-COUMARIN REMARK 900 RELATED ID: 2BYB RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH DEPRENYL REMARK 900 RELATED ID: 2VRM RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH PHENYETHYLHYDRAZINE REMARK 900 RELATED ID: 2C65 RELATED DB: PDB REMARK 900 MAO INHIBITION BY RASAGILINE ANALOGUES REMARK 900 RELATED ID: 2C64 RELATED DB: PDB REMARK 900 MAO INHIBITION BY RASAGILINE ANALOGUES REMARK 900 RELATED ID: 2XCG RELATED DB: PDB REMARK 900 TRANYLCYPROMINE-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH REMARK 900 2-(2- BENZOFURANYL)-2-IMIDAZOLINE REMARK 900 RELATED ID: 1OJ9 RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 1,4-DIPHENYL-2-BUTENE REMARK 900 RELATED ID: 1OJD RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH LAURYLDIMETHYLAMINE-N- REMARK 900 OXIDE (LDAO) REMARK 900 RELATED ID: 2VZ2 RELATED DB: PDB REMARK 900 HUMAN MAO B IN COMPLEX WITH MOFEGILINE REMARK 900 RELATED ID: 1S3B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-METHYL-N-PROPARGYL-1(R)- REMARK 900 AMINOINDAN REMARK 900 RELATED ID: 2C66 RELATED DB: PDB REMARK 900 MAO INHIBITION BY RASAGILINE ANALOGUES REMARK 900 RELATED ID: 2BK4 RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH RASAGILINE REMARK 900 RELATED ID: 2BK5 RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH ISATIN REMARK 900 RELATED ID: 1H8R RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE TYPE B (TRUNCATED) REMARK 900 RELATED ID: 2C70 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 2C75 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 2BK3 RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH FARNESOL REMARK 900 RELATED ID: 2V61 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7- REMARK 900 (3-CHLOROBENZYLOXY )-4-(METHYLAMINO)METHYL-COUMARIN REMARK 900 RELATED ID: 2C72 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 1S2Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(S)- REMARK 900 AMINOINDAN REMARK 900 RELATED ID: 1GOS RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B REMARK 900 RELATED ID: 1S2Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(R)- REMARK 900 AMINOINDAN (RASAGILINE) REMARK 900 RELATED ID: 2C76 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 2VRL RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH BENZYLHYDRAZINE REMARK 900 RELATED ID: 1OJC RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH N-(2-AMINOETHYL)-P- REMARK 900 CHLOROBENZAMIDE REMARK 900 RELATED ID: 2XFO RELATED DB: PDB REMARK 900 TRANYLCYPROMINE-INHIBITED HUMAN MONOAMINE OXIDASE B ILE199ALA REMARK 900 MUTANT IN COMPLEX WITH 2-(2-BENZOFURANYL)-2-IMIDAZOLINE REMARK 900 RELATED ID: 2XFN RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL)-2- REMARK 900 IMIDAZOLINE REMARK 900 RELATED ID: 2XFP RELATED DB: PDB REMARK 900 ISATIN-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2- REMARK 900 BENZOFURANYL)-2- IMIDAZOLINE DBREF 2XFQ A 1 520 UNP P27338 AOFB_HUMAN 1 520 DBREF 2XFQ B 1 520 UNP P27338 AOFB_HUMAN 1 520 SEQRES 1 A 520 MET SER ASN LYS CYS ASP VAL VAL VAL VAL GLY GLY GLY SEQRES 2 A 520 ILE SER GLY MET ALA ALA ALA LYS LEU LEU HIS ASP SER SEQRES 3 A 520 GLY LEU ASN VAL VAL VAL LEU GLU ALA ARG ASP ARG VAL SEQRES 4 A 520 GLY GLY ARG THR TYR THR LEU ARG ASN GLN LYS VAL LYS SEQRES 5 A 520 TYR VAL ASP LEU GLY GLY SER TYR VAL GLY PRO THR GLN SEQRES 6 A 520 ASN ARG ILE LEU ARG LEU ALA LYS GLU LEU GLY LEU GLU SEQRES 7 A 520 THR TYR LYS VAL ASN GLU VAL GLU ARG LEU ILE HIS HIS SEQRES 8 A 520 VAL LYS GLY LYS SER TYR PRO PHE ARG GLY PRO PHE PRO SEQRES 9 A 520 PRO VAL TRP ASN PRO ILE THR TYR LEU ASP HIS ASN ASN SEQRES 10 A 520 PHE TRP ARG THR MET ASP ASP MET GLY ARG GLU ILE PRO SEQRES 11 A 520 SER ASP ALA PRO TRP LYS ALA PRO LEU ALA GLU GLU TRP SEQRES 12 A 520 ASP ASN MET THR MET LYS GLU LEU LEU ASP LYS LEU CYS SEQRES 13 A 520 TRP THR GLU SER ALA LYS GLN LEU ALA THR LEU PHE VAL SEQRES 14 A 520 ASN LEU CYS VAL THR ALA GLU THR HIS GLU VAL SER ALA SEQRES 15 A 520 LEU TRP PHE LEU TRP TYR VAL LYS GLN CYS GLY GLY THR SEQRES 16 A 520 THR ARG ILE ILE SER THR THR ASN GLY GLY GLN GLU ARG SEQRES 17 A 520 LYS PHE VAL GLY GLY SER GLY GLN VAL SER GLU ARG ILE SEQRES 18 A 520 MET ASP LEU LEU GLY ASP ARG VAL LYS LEU GLU ARG PRO SEQRES 19 A 520 VAL ILE TYR ILE ASP GLN THR ARG GLU ASN VAL LEU VAL SEQRES 20 A 520 GLU THR LEU ASN HIS GLU MET TYR GLU ALA LYS TYR VAL SEQRES 21 A 520 ILE SER ALA ILE PRO PRO THR LEU GLY MET LYS ILE HIS SEQRES 22 A 520 PHE ASN PRO PRO LEU PRO MET MET ARG ASN GLN MET ILE SEQRES 23 A 520 THR ARG VAL PRO LEU GLY SER VAL ILE LYS CYS ILE VAL SEQRES 24 A 520 TYR TYR LYS GLU PRO PHE TRP ARG LYS LYS ASP TYR CYS SEQRES 25 A 520 GLY THR MET ILE ILE ASP GLY GLU GLU ALA PRO VAL ALA SEQRES 26 A 520 TYR THR LEU ASP ASP THR LYS PRO GLU GLY ASN TYR ALA SEQRES 27 A 520 ALA ILE MET GLY PHE ILE LEU ALA HIS LYS ALA ARG LYS SEQRES 28 A 520 LEU ALA ARG LEU THR LYS GLU GLU ARG LEU LYS LYS LEU SEQRES 29 A 520 CYS GLU LEU TYR ALA LYS VAL LEU GLY SER LEU GLU ALA SEQRES 30 A 520 LEU GLU PRO VAL HIS TYR GLU GLU LYS ASN TRP CYS GLU SEQRES 31 A 520 GLU GLN TYR SER GLY GLY CYS TYR THR THR TYR PHE PRO SEQRES 32 A 520 PRO GLY ILE LEU THR GLN TYR GLY ARG VAL LEU ARG GLN SEQRES 33 A 520 PRO VAL ASP ARG ILE TYR PHE ALA GLY THR GLU THR ALA SEQRES 34 A 520 THR HIS TRP SER GLY TYR MET GLU GLY ALA VAL GLU ALA SEQRES 35 A 520 GLY GLU ARG ALA ALA ARG GLU ILE LEU HIS ALA MET GLY SEQRES 36 A 520 LYS ILE PRO GLU ASP GLU ILE TRP GLN SER GLU PRO GLU SEQRES 37 A 520 SER VAL ASP VAL PRO ALA GLN PRO ILE THR THR THR PHE SEQRES 38 A 520 LEU GLU ARG HIS LEU PRO SER VAL PRO GLY LEU LEU ARG SEQRES 39 A 520 LEU ILE GLY LEU THR THR ILE PHE SER ALA THR ALA LEU SEQRES 40 A 520 GLY PHE LEU ALA HIS LYS ARG GLY LEU LEU VAL ARG VAL SEQRES 1 B 520 MET SER ASN LYS CYS ASP VAL VAL VAL VAL GLY GLY GLY SEQRES 2 B 520 ILE SER GLY MET ALA ALA ALA LYS LEU LEU HIS ASP SER SEQRES 3 B 520 GLY LEU ASN VAL VAL VAL LEU GLU ALA ARG ASP ARG VAL SEQRES 4 B 520 GLY GLY ARG THR TYR THR LEU ARG ASN GLN LYS VAL LYS SEQRES 5 B 520 TYR VAL ASP LEU GLY GLY SER TYR VAL GLY PRO THR GLN SEQRES 6 B 520 ASN ARG ILE LEU ARG LEU ALA LYS GLU LEU GLY LEU GLU SEQRES 7 B 520 THR TYR LYS VAL ASN GLU VAL GLU ARG LEU ILE HIS HIS SEQRES 8 B 520 VAL LYS GLY LYS SER TYR PRO PHE ARG GLY PRO PHE PRO SEQRES 9 B 520 PRO VAL TRP ASN PRO ILE THR TYR LEU ASP HIS ASN ASN SEQRES 10 B 520 PHE TRP ARG THR MET ASP ASP MET GLY ARG GLU ILE PRO SEQRES 11 B 520 SER ASP ALA PRO TRP LYS ALA PRO LEU ALA GLU GLU TRP SEQRES 12 B 520 ASP ASN MET THR MET LYS GLU LEU LEU ASP LYS LEU CYS SEQRES 13 B 520 TRP THR GLU SER ALA LYS GLN LEU ALA THR LEU PHE VAL SEQRES 14 B 520 ASN LEU CYS VAL THR ALA GLU THR HIS GLU VAL SER ALA SEQRES 15 B 520 LEU TRP PHE LEU TRP TYR VAL LYS GLN CYS GLY GLY THR SEQRES 16 B 520 THR ARG ILE ILE SER THR THR ASN GLY GLY GLN GLU ARG SEQRES 17 B 520 LYS PHE VAL GLY GLY SER GLY GLN VAL SER GLU ARG ILE SEQRES 18 B 520 MET ASP LEU LEU GLY ASP ARG VAL LYS LEU GLU ARG PRO SEQRES 19 B 520 VAL ILE TYR ILE ASP GLN THR ARG GLU ASN VAL LEU VAL SEQRES 20 B 520 GLU THR LEU ASN HIS GLU MET TYR GLU ALA LYS TYR VAL SEQRES 21 B 520 ILE SER ALA ILE PRO PRO THR LEU GLY MET LYS ILE HIS SEQRES 22 B 520 PHE ASN PRO PRO LEU PRO MET MET ARG ASN GLN MET ILE SEQRES 23 B 520 THR ARG VAL PRO LEU GLY SER VAL ILE LYS CYS ILE VAL SEQRES 24 B 520 TYR TYR LYS GLU PRO PHE TRP ARG LYS LYS ASP TYR CYS SEQRES 25 B 520 GLY THR MET ILE ILE ASP GLY GLU GLU ALA PRO VAL ALA SEQRES 26 B 520 TYR THR LEU ASP ASP THR LYS PRO GLU GLY ASN TYR ALA SEQRES 27 B 520 ALA ILE MET GLY PHE ILE LEU ALA HIS LYS ALA ARG LYS SEQRES 28 B 520 LEU ALA ARG LEU THR LYS GLU GLU ARG LEU LYS LYS LEU SEQRES 29 B 520 CYS GLU LEU TYR ALA LYS VAL LEU GLY SER LEU GLU ALA SEQRES 30 B 520 LEU GLU PRO VAL HIS TYR GLU GLU LYS ASN TRP CYS GLU SEQRES 31 B 520 GLU GLN TYR SER GLY GLY CYS TYR THR THR TYR PHE PRO SEQRES 32 B 520 PRO GLY ILE LEU THR GLN TYR GLY ARG VAL LEU ARG GLN SEQRES 33 B 520 PRO VAL ASP ARG ILE TYR PHE ALA GLY THR GLU THR ALA SEQRES 34 B 520 THR HIS TRP SER GLY TYR MET GLU GLY ALA VAL GLU ALA SEQRES 35 B 520 GLY GLU ARG ALA ALA ARG GLU ILE LEU HIS ALA MET GLY SEQRES 36 B 520 LYS ILE PRO GLU ASP GLU ILE TRP GLN SER GLU PRO GLU SEQRES 37 B 520 SER VAL ASP VAL PRO ALA GLN PRO ILE THR THR THR PHE SEQRES 38 B 520 LEU GLU ARG HIS LEU PRO SER VAL PRO GLY LEU LEU ARG SEQRES 39 B 520 LEU ILE GLY LEU THR THR ILE PHE SER ALA THR ALA LEU SEQRES 40 B 520 GLY PHE LEU ALA HIS LYS ARG GLY LEU LEU VAL ARG VAL HET FAD A 600 53 HET RAS A 601 13 HET XCG A 602 14 HET C15 A1503 22 HET FAD B 600 53 HET RAS B 601 13 HET XCG B 602 14 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM RAS (1R)-N-(PROP-2-EN-1-YL)-2,3-DIHYDRO-1H-INDEN-1-AMINE HETNAM XCG 2-(2-BENZOFURANYL)-2-IMIDAZOLINE HETNAM C15 N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE HETSYN RAS RASAGILINE, BOUND FORM FORMUL 3 FAD 2(C27 H33 N9 O15 P2) FORMUL 4 RAS 2(C12 H15 N) FORMUL 5 XCG 2(C11 H8 N2 O) FORMUL 6 C15 C17 H38 N O3 S 1+ FORMUL 10 HOH *472(H2 O) HELIX 1 1 GLY A 13 SER A 26 1 14 HELIX 2 2 GLN A 65 LEU A 75 1 11 HELIX 3 3 ASN A 108 ARG A 127 1 20 HELIX 4 4 ALA A 133 ALA A 137 5 5 HELIX 5 5 LEU A 139 ASN A 145 1 7 HELIX 6 6 THR A 147 CYS A 156 1 10 HELIX 7 7 THR A 158 THR A 174 1 17 HELIX 8 8 SER A 181 GLN A 191 1 11 HELIX 9 9 GLY A 194 SER A 200 1 7 HELIX 10 10 GLY A 215 GLY A 226 1 12 HELIX 11 11 PRO A 265 ILE A 272 5 8 HELIX 12 12 PRO A 279 ILE A 286 1 8 HELIX 13 13 PRO A 304 LYS A 309 1 6 HELIX 14 14 ALA A 346 ALA A 353 1 8 HELIX 15 15 THR A 356 LEU A 372 1 17 HELIX 16 16 SER A 374 GLU A 379 5 6 HELIX 17 17 CYS A 389 GLU A 391 5 3 HELIX 18 18 GLY A 405 GLY A 411 1 7 HELIX 19 19 ARG A 412 LEU A 414 5 3 HELIX 20 20 GLY A 425 ALA A 429 5 5 HELIX 21 21 TYR A 435 MET A 454 1 20 HELIX 22 22 PRO A 458 ILE A 462 5 5 HELIX 23 23 THR A 480 LEU A 486 1 7 HELIX 24 24 SER A 488 THR A 500 1 13 HELIX 25 25 GLY B 13 SER B 26 1 14 HELIX 26 26 GLN B 65 LEU B 75 1 11 HELIX 27 27 ASN B 108 ARG B 127 1 20 HELIX 28 28 ALA B 133 ALA B 137 5 5 HELIX 29 29 LEU B 139 ASN B 145 1 7 HELIX 30 30 THR B 147 CYS B 156 1 10 HELIX 31 31 THR B 158 THR B 174 1 17 HELIX 32 32 SER B 181 GLN B 191 1 11 HELIX 33 33 GLY B 194 SER B 200 1 7 HELIX 34 34 GLY B 215 GLY B 226 1 12 HELIX 35 35 PRO B 265 ILE B 272 5 8 HELIX 36 36 PRO B 279 ILE B 286 1 8 HELIX 37 37 PRO B 304 LYS B 309 5 6 HELIX 38 38 ALA B 346 ALA B 353 1 8 HELIX 39 39 THR B 356 GLY B 373 1 18 HELIX 40 40 SER B 374 GLU B 379 5 6 HELIX 41 41 CYS B 389 GLU B 391 5 3 HELIX 42 42 GLY B 405 GLY B 411 1 7 HELIX 43 43 ARG B 412 LEU B 414 5 3 HELIX 44 44 GLY B 425 ALA B 429 5 5 HELIX 45 45 TYR B 435 MET B 454 1 20 HELIX 46 46 PRO B 458 ILE B 462 5 5 HELIX 47 47 THR B 480 LEU B 486 1 7 HELIX 48 48 SER B 488 LEU B 495 1 8 SHEET 1 AA 5 VAL A 229 LYS A 230 0 SHEET 2 AA 5 VAL A 30 LEU A 33 1 O VAL A 32 N LYS A 230 SHEET 3 AA 5 VAL A 7 VAL A 10 1 O VAL A 7 N VAL A 31 SHEET 4 AA 5 TYR A 259 SER A 262 1 O TYR A 259 N VAL A 8 SHEET 5 AA 5 ILE A 421 PHE A 423 1 O TYR A 422 N SER A 262 SHEET 1 AB 2 THR A 45 LEU A 46 0 SHEET 2 AB 2 VAL A 54 ASP A 55 -1 O VAL A 54 N LEU A 46 SHEET 1 AC 3 TYR A 60 VAL A 61 0 SHEET 2 AC 3 ARG A 208 PHE A 210 -1 O ARG A 208 N VAL A 61 SHEET 3 AC 3 THR A 79 LYS A 81 -1 O TYR A 80 N LYS A 209 SHEET 1 AD 7 LYS A 95 PHE A 99 0 SHEET 2 AD 7 ARG A 87 VAL A 92 -1 O LEU A 88 N PHE A 99 SHEET 3 AD 7 TYR A 311 ILE A 317 1 N CYS A 312 O ARG A 87 SHEET 4 AD 7 TYR A 326 ASP A 329 -1 O THR A 327 N MET A 315 SHEET 5 AD 7 ALA A 339 LEU A 345 -1 O MET A 341 N LEU A 328 SHEET 6 AD 7 VAL A 294 TYR A 300 -1 O ILE A 295 N ILE A 344 SHEET 7 AD 7 HIS A 382 ASN A 387 -1 O HIS A 382 N TYR A 300 SHEET 1 AE 4 MET A 254 ALA A 257 0 SHEET 2 AE 4 VAL A 245 THR A 249 -1 O VAL A 245 N ALA A 257 SHEET 3 AE 4 VAL A 235 ASP A 239 -1 N ILE A 236 O GLU A 248 SHEET 4 AE 4 HIS A 273 ASN A 275 1 O HIS A 273 N ILE A 238 SHEET 1 BA 5 VAL B 229 LEU B 231 0 SHEET 2 BA 5 VAL B 30 GLU B 34 1 O VAL B 32 N LYS B 230 SHEET 3 BA 5 VAL B 7 VAL B 10 1 O VAL B 7 N VAL B 31 SHEET 4 BA 5 TYR B 259 SER B 262 1 O TYR B 259 N VAL B 8 SHEET 5 BA 5 ILE B 421 PHE B 423 1 O TYR B 422 N SER B 262 SHEET 1 BB 2 THR B 45 ASN B 48 0 SHEET 2 BB 2 LYS B 52 ASP B 55 -1 O LYS B 52 N ASN B 48 SHEET 1 BC 3 TYR B 60 VAL B 61 0 SHEET 2 BC 3 ARG B 208 PHE B 210 -1 O ARG B 208 N VAL B 61 SHEET 3 BC 3 THR B 79 LYS B 81 -1 O TYR B 80 N LYS B 209 SHEET 1 BD 7 LYS B 95 PHE B 99 0 SHEET 2 BD 7 ARG B 87 VAL B 92 -1 O LEU B 88 N PHE B 99 SHEET 3 BD 7 TYR B 311 ILE B 317 1 N CYS B 312 O ARG B 87 SHEET 4 BD 7 TYR B 326 ASP B 329 -1 O THR B 327 N MET B 315 SHEET 5 BD 7 ALA B 339 LEU B 345 -1 O MET B 341 N LEU B 328 SHEET 6 BD 7 VAL B 294 TYR B 300 -1 O ILE B 295 N ILE B 344 SHEET 7 BD 7 HIS B 382 ASN B 387 -1 O HIS B 382 N TYR B 300 SHEET 1 BE 4 MET B 254 ALA B 257 0 SHEET 2 BE 4 VAL B 245 THR B 249 -1 O VAL B 245 N ALA B 257 SHEET 3 BE 4 VAL B 235 ASP B 239 -1 N ILE B 236 O GLU B 248 SHEET 4 BE 4 HIS B 273 ASN B 275 1 O HIS B 273 N ILE B 238 LINK SG CYS A 397 C8M FAD A 600 1555 1555 1.65 LINK N5 FAD A 600 C13 RAS A 601 1555 1555 1.67 LINK SG CYS B 397 C8M FAD B 600 1555 1555 1.67 LINK N5 FAD B 600 C13 RAS B 601 1555 1555 1.64 CISPEP 1 ASN A 275 PRO A 276 0 1.78 CISPEP 2 CYS A 397 TYR A 398 0 -1.36 CISPEP 3 ASN B 275 PRO B 276 0 -1.73 CISPEP 4 CYS B 397 TYR B 398 0 -2.88 SITE 1 AC1 7 LEU A 88 PRO A 102 LEU A 164 LEU A 167 SITE 2 AC1 7 ILE A 199 ILE A 316 TYR A 326 SITE 1 AC2 5 TRP A 107 ASP A 153 LYS A 154 CYS A 156 SITE 2 AC2 5 TRP A 157 SITE 1 AC3 9 LEU B 88 PRO B 102 LEU B 164 LEU B 167 SITE 2 AC3 9 LEU B 171 ILE B 199 ILE B 316 TYR B 326 SITE 3 AC3 9 HOH B2049 SITE 1 AC4 42 GLY A 11 GLY A 13 ILE A 14 SER A 15 SITE 2 AC4 42 LEU A 33 GLU A 34 ALA A 35 ARG A 36 SITE 3 AC4 42 GLY A 41 ARG A 42 THR A 43 GLY A 57 SITE 4 AC4 42 GLY A 58 SER A 59 TYR A 60 LEU A 171 SITE 5 AC4 42 CYS A 172 ILE A 198 GLN A 206 PRO A 234 SITE 6 AC4 42 VAL A 235 ALA A 263 ILE A 264 TYR A 326 SITE 7 AC4 42 TRP A 388 TYR A 393 CYS A 397 TYR A 398 SITE 8 AC4 42 GLY A 425 THR A 426 GLY A 434 TYR A 435 SITE 9 AC4 42 MET A 436 ALA A 439 HOH A2009 HOH A2030 SITE 10 AC4 42 HOH A2123 HOH A2208 HOH A2209 HOH A2210 SITE 11 AC4 42 HOH A2211 HOH A2212 SITE 1 AC5 43 VAL B 10 GLY B 11 GLY B 13 ILE B 14 SITE 2 AC5 43 SER B 15 LEU B 33 GLU B 34 ALA B 35 SITE 3 AC5 43 ARG B 36 GLY B 40 GLY B 41 ARG B 42 SITE 4 AC5 43 GLY B 57 GLY B 58 SER B 59 TYR B 60 SITE 5 AC5 43 CYS B 172 ILE B 198 ILE B 199 GLN B 206 SITE 6 AC5 43 PRO B 234 VAL B 235 ALA B 263 ILE B 264 SITE 7 AC5 43 TYR B 326 TRP B 388 TYR B 393 CYS B 397 SITE 8 AC5 43 TYR B 398 GLY B 425 THR B 426 GLY B 434 SITE 9 AC5 43 TYR B 435 MET B 436 ALA B 439 HOH B2017 SITE 10 AC5 43 HOH B2254 HOH B2255 HOH B2256 HOH B2257 SITE 11 AC5 43 HOH B2258 HOH B2259 HOH B2260 CRYST1 131.510 223.380 86.550 90.00 90.00 90.00 C 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007604 0.000000 0.000000 0.00000 SCALE2 0.000000 0.004477 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011554 0.00000